Aguitong, Ariston .

HRN: 23-28-45  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/26/2025
09/01/2025
IV
1.5g
Q8
Cap Hr
Checking Initial Appropriateness 
08/26/2025
LEVOFLOXACIN 500MG (TAB)
08/26/2025
09/01/2025
PO
750 Mg
Of
Cap Hr
Checking Initial Appropriateness 
08/31/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/31/2025
09/06/2025
IV
4.5g
Q8h
Capmr
Rejected 
09/04/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/04/2025
09/11/2025
IV
4.5g
Q6
CAP MR
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: